李 忠達

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Neoplasms 67%
3. Pancreatic Neoplasms 39%
4. capmatinib 34%
5. Class III Phosphatidylinositol 3-Kinases 29%
6. AT-Hook Motifs 27%
7. Aryl Hydrocarbon Receptor Nuclear Translocator 26%
8. Carcinogenesis 26%
9. Pyruvate Dehydrogenase (Acetyl-Transferring) Kinase 25%
10. Survival 23%
11. Epigenomics 23%
12. Carcinoma 22%
13. Adenocarcinoma 21%
14. human ERBB2 protein 20%
15. Squamous Cell Carcinoma of Head and Neck 18%
16. Polyps 18%
17. CDC2 Protein Kinase 17%
18. Urinary Bladder Neoplasms 17%
19. Therapeutics 17%
20. Epidermal Growth Factor 16%
21. Inflammatory Bowel Diseases 15%
22. Systemic Lupus Erythematosus 15%
23. RON protein 14%
24. Non-Small Cell Lung Carcinoma 14%
25. rice bran saccharide 14%
26. Y-Box-Binding Protein 1 13%
27. Mucinoses 13%
28. Colitis 13%
29. Mucous Membrane 13%
30. Hepatocellular Carcinoma 13%
31. Genes 13%
32. Heterogeneous-Nuclear Ribonucleoproteins 13%
33. M Phase Cell Cycle Checkpoints 13%
34. Mutation 13%
35. trametinib 13%
36. Thyroglossal Cyst 12%
37. Colonic Neoplasms 12%
38. Pulmonary Alveolar Proteinosis 12%
39. integrin-linked kinase 12%